Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices

Contraception

Volumn 92, Issue 6, 2015, Pages 532-535

  Woo, Irene ^a   Seifert, Sara ^a   Hendricks, Dacia ^c   Jamshidi, Roxanne M ^b   Burke, Anne E ^b   Fox, Michelle C ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

contraception compliance; contraception continuation; Long acting reversible contraception; postpartum contraception

Indexed keywords

ADULT; ARTICLE; BLEEDING; COHORT ANALYSIS; FEMALE; FEMALE CONTRACEPTIVE DEVICE; HUMAN; HUMAN EXPERIMENT; INTRAUTERINE CONTRACEPTIVE DEVICE; INTRAUTERINE DEVICE EXPULSION; MEDICAL DEVICE COMPLICATION; MULTICENTER STUDY; PAIN; PATIENT SATISFACTION; PROSPECTIVE STUDY; PUERPERIUM; ADVERSE EFFECTS; CONTRACEPTION; DRUG IMPLANT; FOLLOW UP; PATIENT COMPLIANCE; PREGNANCY; PROCEDURES; STATISTICS AND NUMERICAL DATA; THERAPEUTIC USE; TIME FACTOR;

CONTRACEPTIVE AGENT; DRUG IMPLANT;

ADULT; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAUTERINE DEVICE EXPULSION; INTRAUTERINE DEVICES; PATIENT COMPLIANCE; PATIENT SATISFACTION; POSTPARTUM PERIOD; PREGNANCY; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84960471269     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2015.09.007     Document Type: Article

References (22)

1. P.D. Blumenthal, A. Voedisch, and K. Gemzell-Danielsson Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception Hum Reprod Update 17 1 2011 121 137
2. J.E. Stuart, G.M. Secura, Q. Zhao, M.E. Pittman, and J.F. Peipert Factors associated with 12-month discontinuation among contraceptive pill, patch, and ring users Obstet Gynecol 121 2 Pt 1 2013 330 336
3. L.N. Lewis, D.A. Doherty, M. Hickey, and S.R. Skinner Implanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancy Contraception 81 5 2010 421 426
4. K. Daniels, J. Daugherty, and J. Jones Current contraceptive status among women aged 15-44: United States, 2011-2013 National Health Statistics Reports, No. 173 2014 National Center for Health Statistics Hyattsville, MD
5. A. Gemmill, and L.D. Lindberg Short interpregnancy intervals in the United States Obstet Gynecol 122 1 2013 64 71
6. M.B. Brito, R.A. Ferriani, S.M. Quintana, M.E. Yazlle, M.F. Silva de Sa, and C.S. Vieira Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study Contraception 80 6 2009 519 526
7. J.A. Ogburn, E. Espey, and J. Stonehocker Barriers to intrauterine device insertion in postpartum women Contraception 72 6 2005 426 429
8. B.A. Chen, M.F. Reeves, J.L. Hayes, H.L. Hohmann, L.K. Perriera, and M.D. Creinin Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial Obstet Gynecol 116 5 2010 1079 1087
9. S. Celen, P. Moroy, A. Sucak, A. Aktulay, and N. Danisman Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices Contraception 69 4 2004 279 282
10. D.A. Grimes, L.M. Lopez, K.F. Schulz, H.A. Van Vliet, and N.L. Stanwood Immediate post-partum insertion of intrauterine devices Cochrane Database Syst Rev 5 2010 Cd003036 10.1002/14651858.CD003498.pub3
11. B. Kaneshiro, and T. Aeby Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device Int J Womens Health 2 2010 211 220
12. N. Kapp, and K.M. Curtis Intrauterine device insertion during the postpartum period: a systematic review Contraception 80 4 2009 327 336
13. J.X. Xu, R. Rivera, T.R. Dunson, and et al. A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People's Republic of China Contraception 54 1996 33 38 [United States]
14. T. Luukkainen, H. Allonen, M. Haukkamaa, and et al. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study Contraception 36 2 1987 169 179
15. J.F. Peipert, Q. Zhao, J.E. Allsworth, and et al. Continuation and satisfaction of reversible contraception Obstet Gynecol 117 5 2011 1105 1113
16. J.T. Jensen, A.L. Nelson, and A.C. Costales Subject and clinician experience with the levonorgestrel-releasing intrauterine system Contraception 77 2008 22 29 [United States]
17. I. Sivin, S. el Mahgoub, T. McCarthy, and et al. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study Contraception 42 4 1990 361 378
18. M. Short, D. Dallay, S. Omokanye, J.U. Hanisch, and P. Inki Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study Eur J Contracept Reprod Health Care 17 1 2012 79 88
19. A.M. Teunissen, B. Grimm, and F.J. Roumen Continuation rates of the subdermal contraceptive Implanon((R)) and associated influencing factors Eur J Contracept Reprod Health Care 19 1 2014 15 21
20. S. Wilson, C. Tennant, M.D. Sammel, and C. Schreiber Immediate postpartum etonogestrel implant: a contraception option with long-term continuation Contraception 90 3 2014 259 264
21. J. Trussell, A.M. Lalla, Q.V. Doan, E. Reyes, L. Pinto, and J. Gricar Cost effectiveness of contraceptives in the United States Contraception 79 1 2009 5 14
22. J. Trussell, F. Hassan, J. Lowin, A. Law, and A. Filonenko Achieving cost-neutrality with long-acting reversible contraceptive methods Contraception 91 1 2014 49 56